Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhage
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 334 participants.
Also called NCT05132920
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 334 participants
- Registry
-
NCT05132920 -
2021-000732-54
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT05132920. Randomized; quadruple masking; primary purpose treatment. Start 2021-12-03 (actual); primary completion 2024-09-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhage
- Acronym
- FINISHER
- Condition
- Aneurysmal Subarachnoid Hemorrhage
- Intervention (Drug)
- Dexamethasone
- Intervention (Drug)
- Placebo
- Lead sponsor
- University Hospital, Bonn
- Collaborator
- German Federal Ministry of Education and Research
- Collaborator
- Pharmacy of the University Hospital Leipzig- AöR
- Collaborator
- nextevidence GmbH
Record details
- Record id
cardio:ct-nct05132920- Content hash
4a253bf60f34de5f098b5d3558b0593587624bdae2cd26b3e4193231a6923577